ArticleAnnals of hematology2025

Combination of disease burden before allogeneic transplantation and early post-transplant minimal residual disease predicts survival in patients with acute myeloid leukemia.

Claudia Núñez-Torrón Stock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.